Caliber Imagng&Diagnstics (LCDX) Stock Price, News & Analysis
Price Move History
- Daily moves over 5%
- 12 83 sessions, October 27, 2025 to October 28, 2026
- Largest daily move
- +500% close of October 8, 2026
- 1-year change
- +50% closing prices, October 27, 2025 to October 28, 2026
- 1-month change
- +500% closing prices, September 23, 2026 to October 28, 2026
Company Description
Caliber Imagng&Diagnstics (OTC: LCDX) is classified in the medical devices industry within the Healthcare sector and carries a market capitalization of $5.1K.
LCDX gained 50.0% in the 12 months to October 28, 2026. The last closing price was $0.0006.
This page collects what Stock Titan holds for LCDX, including price data and short interest trends.
Stock Performance
Caliber Imagng&Diagnstics (LCDX) closed at $0.0006 on October 28, 2026. In the 12 months to October 28, 2026, the price gained 50.0%.
LCDX Metrics & Rankings
Price returns through October 28, 2026. Month and year figures include the first trading day. Ranking links may use different dates.
Short Interest History
Short interest in Caliber Imagng&Diagnstics (LCDX) currently stands at 3.0 thousand shares, representing 0.0% of the float.
Days to Cover History
Days to cover for Caliber Imagng&Diagnstics (LCDX) currently stands at 3.2 days, up 167.2% from the previous period. The ratio is the reported short interest divided by the average daily trading volume. Since November 2025, the figure has increased by 218%. Across the settlements charted above, it has ranged from 1.0 to 17.9 days.
LCDX Company Profile & Sector Positioning
Caliber Imagng&Diagnstics (LCDX) operates in the Medical Devices industry within the broader Healthcare sector and is listed on the OTC.
Investors comparing LCDX often look at related companies in the same sector, including Nemaura Medical Inc (NMRD), BIOLASE Inc (BIOLQ), Pressure BioSciences (PBIO), Acutus Medical Inc (AFIB), and Vicarious Srgcl Inc A (RBOT). Comparing financial metrics, valuation ratios, and stock performance across these peers can help investors evaluate LCDX's relative position within its industry.